Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Under Google’s updated inactive account policy, which the tech giant announced back in May, accounts that haven’t been used in at least two years could be deleted. Accounts deemed inactive could be erased beginning Friday.
Supporting nonprofits on GivingTuesday this year could have a bigger impact than usual. Why? Because nonprofits and industry groups say donations so far are down compared with previous years.
